Trial
NCT00582790
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Novartis
Condition
Kidney Cancer
Intervention
IL2
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-25